Recurrent and metastatic endometrial and ovarian cancers can be notoriously difficult to treat: They have spread to other organs and typically have developed resistance to chemotherapy; and patients already heavily treated with chemotherapy may not be able to endure more chemo. Now, physicians have shown that a combination of two chemotherapy drugs not only produced clinical benefit for such patients but were also well tolerated.
Full article >>
Tuesday, April 28, 2009
New Treatment Shows Promise Against Recurrent Gynecologic Cancers
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment